Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism.

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Conditional false discovery rate Genome wide association study Pulmonary Hypertension Pulmonary embolism

Journal

American journal of respiratory and critical care medicine
ISSN: 1535-4970
Titre abrégé: Am J Respir Crit Care Med
Pays: United States
ID NLM: 9421642

Informations de publication

Date de publication:
12 Mar 2024
Historique:
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 12 3 2024
Statut: aheadofprint

Résumé

Chronic Thromboembolic Pulmonary Hypertension involves formation and non-resolution of thrombus, dysregulated inflammation, angiogenesis and the development of a small vessel vasculopathy. We aimed to establish the genetic basis of chronic thromboembolic pulmonary hypertension to gain insight into its pathophysiological contributors. We conducted a genome-wide association study on 1907 European cases and 10363 European controls. We co-analysed our results with existing results from genome-wide association studies on deep vein thrombosis, pulmonary embolism and idiopathic pulmonary arterial hypertension. Our primary association study revealed genetic associations at the ABO, FGG, F11, MYH7B, and HLA-DRA loci. Through our co-analysis we demonstrate further associations with chronic thromboembolic pulmonary hypertension at the F2, TSPAN15, SLC44A2 and F5 loci but find no statistically significant associations shared with idiopathic pulmonary arterial hypertension. Chronic thromboembolic pulmonary hypertension is a partially heritable polygenic disease, with related though distinct genetic associations to pulmonary embolism and to deep vein thrombosis.

Identifiants

pubmed: 38470220
doi: 10.1164/rccm.202307-1236OC
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

James Liley (J)

Durham University, 3057, Mathematical Sciences, Durham, United Kingdom of Great Britain and Northern Ireland.

Michael Newnham (M)

University of Birmingham, 1724, Birmingham, United Kingdom of Great Britain and Northern Ireland.

Marta Bleda (M)

University of Cambridge, 2152, Cambridge, United Kingdom of Great Britain and Northern Ireland.

Katherine Bunclark (K)

Papworth Hospital NHS Foundation Trust, 2144, Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland.

William Auger (W)

UCSD, 8784, La Jolla, California, United States.

Joan Albert Barbera (JA)

Hospital Clinic, Barcelona, Spain.

Harm Bogaard (H)

Vrije Universiteit Amsterdam, 1190, Pulmonary Medicine, Amsterdam, Noord-Holland, Netherlands.

Marion Delcroix (M)

UZ Leuven, Leuven, Belgium.

Timothy M Fernandes (TM)

University of California, San Diego, Division of Pulmonary and Critical Care Medicine, La Jolla, California, United States.

Luke Howard (L)

Imperial College, National Heart & Lung Institute, London, United Kingdom of Great Britain and Northern Ireland.

David Jenkins (D)

Papworth Hospital NHS Foundation Trust, 2144, Cardiac Surgery, Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland.

Irene Lang (I)

Medical University of Vienna, Cardiology, Vienna, Austria.

Eckhard Mayer (E)

Kerckhoff-Klinik , Department of Thoracic Surgery, Bad Nauheim, Germany.

Chris Rhodes (C)

Imperial College London, National Heart & Lung Institute, London, United Kingdom of Great Britain and Northern Ireland.

Michael Simpson (M)

King's College London, 4616, London, United Kingdom of Great Britain and Northern Ireland.

Laura Southgate (L)

University of London St George's, 4915, Molecular and Clinical Sciences Research Institute, London, United Kingdom of Great Britain and Northern Ireland.

Richard Trembath (R)

King's College London, London, United Kingdom of Great Britain and Northern Ireland.

John Wharton (J)

Imperial College London, Experimental Medicine & Toxicology, London, United Kingdom of Great Britain and Northern Ireland.

Martin R Wilkins (MR)

Imperial College London, London, United Kingdom of Great Britain and Northern Ireland.

Stefan Gräf (S)

University of Cambridge, 2152, Department of Medicine, Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland.

Nicholas Morrell (N)

University of Cambridge, Cambridge, United Kingdom of Great Britain and Northern Ireland.

Joanna Pepke Zaba (J)

Papworth Hospital NHS Foundation Trust, 2144, Pulmonary Vascular Disease Unit, Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland.

Mark Toshner (M)

Papworth Hospital NHS Foundation Trust, Pulmonary Vascular Diseases Unit, Cambridge, United Kingdom of Great Britain and Northern Ireland; mrt34@medschl.cam.ac.uk.

Classifications MeSH